Earnings

UPDATE: GSK Q3 Adj. EPS $1.47 Beats $1.40 Estimate, Sales $11.948B Beat $11.800B Estimate

Oct 28, 2026 · 10:23 AM ET· updated 53m ago

GSK (NYSE:GSK) reported quarterly earnings of $1.47 per share which beat the analyst consensus estimate of $1.40 by 5 percent. This is a 0.68 percent decrease over earnings of $1.48 per share from the same period last

Why It Matters

GSK made more money per share than experts predicted this quarter. When a company beats its goals, it shows the business is running well and the team is doing smart things.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

GSK49.15

-1.79 (-3.51%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.